GSK PLC SP. ADR/2 NEW (GS70) — Working Capital to Net Assets Ratio
GSK PLC SP. ADR/2 NEW (GS70) has a Working Capital to Net Assets ratio of -23.1% as of June 2026. Working capital of €-3.98 Billion (current assets of €17.56 Billion minus current liabilities of €21.53 Billion) is measured against net assets of €17.18 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See GS70 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
GSK PLC SP. ADR/2 NEW Working Capital to Net Assets (2021–2025)
This chart shows how GSK PLC SP. ADR/2 NEW's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the ratio stands at -23.1%, reflecting working capital of €-3.98 Billion against net assets of €17.18 Billion EUR. For the complete balance sheet picture, see GS70 total assets.
Annual Working Capital to Net Assets for GSK PLC SP. ADR/2 NEW (2021–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check GSK PLC SP. ADR/2 NEW liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -24.3% | €-3.88 Billion | €15.96 Billion | €17.51 Billion | €21.39 Billion | ▲ +11.6 pp |
| 2024 | -35.9% | €-4.70 Billion | €13.09 Billion | €17.00 Billion | €21.70 Billion | ▼ -17.0 pp |
| 2023 | -18.9% | €-2.42 Billion | €12.79 Billion | €18.64 Billion | €21.07 Billion | ▲ +1.3 pp |
| 2022 | -20.2% | €-2.04 Billion | €10.10 Billion | €20.77 Billion | €22.81 Billion | ▲ +3.2 pp |
| 2021 | -23.4% | €-5.00 Billion | €21.34 Billion | €18.67 Billion | €23.67 Billion | — |